Search

Search Results

• The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov

  326-339

  01.10.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

  Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin

  145-152

  01.04.2025

• Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

  Arman Vachakanovich Arakelyan, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, I.S. Monin, N.M. Zolotaikina, G.D. Petrova, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, V.Yu. Kirsanov

  38-50

  01.01.2025

• Diffuse Large B-Cell Lymphoma with High Risk of Central Nervous System Damage: A Literature Review, Prevention, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, I.Z. Zavodnova, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, U.G. Koshkina, G.S. Tumyan

  51-64

  01.01.2025

• Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients Aged over 60 Years

  Ivan Ivanovich Kostroma, V.A. Yudina, R.R. Sabitova, E.S. Stepchenkova, Zh.V. Chubukina, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  287-293

  09.06.2023

• Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

  Mariya Sergeevna Voitko, T.I. Pospelova, I.N. Nechunaeva, Ya.Yu. Shebunyaeva

  192-199

  03.03.2023

• Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  88-95

  01.01.2023

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• Efficacy and Safety of Pola-BR Combination in Relapsed/Refractory Aggressive В-Cell Non-Hodgkin’s Lymphomas: A Russian Multi-Center Study

  Olesya Gennadevna Smykova, A.A. Semenova, Yu.B. Chernykh, T.A. Mitina, A.V. Kildyushevskii, S.K. Kravchenko, A.E. Misyurina, A.U. Magomedova, E.A. Baryakh, S.V. Samarina, N.P. Volkov, V.V. Markelov, P.V. Kotselyabina, L.V. Fedorova, K.V. Lepik, E.V. Kondakova, L.V. Stelmakh, V.V. Baykov, N.B. Mikhailova, I.S. Moiseev, G.S. Tumyan, E.A. Osmanov, A.D. Kulagin

  232-239

  01.07.2022

• Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study

  T.I. Ionova, O.Yu. Vinogradova, Yu.B. Kochkareva, E.E. Markova, K.D. Kaplanov, M.N. Shirokova, T.V. Shelekhova, A.N. Levanov, A.V. Kopylova, O.Yu. Li, T.A. Mitina, O.A. Rukavitsyn, P.I. Simashova, L.V. Anchukova, E.N. Babich, S.A. Volkova, D.B. Dasheeva, M.V. Demchenkova, S.K. Dubov, T.V. Esenina, L.E. Ivanova, T.L. Kravchuk, E.V. Rimashevskaya, M.T. Savinova, N.O. Saraeva, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin

  240-252

  01.07.2022

• Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects

  Anna Yurevna Aksenova, A.S. Zhuk, E.I. Stepchenkova, S.V. Gritsaev

  259-270

  01.07.2022

• Significance of the Expression of pAKT1 and pSyk Activation Proteins in Diffuse Large B-Cell Lymphoma

  Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, S.V. Samarina, I.V. Paramonov

  140-147

  01.04.2022

• Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

  Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin

  28-41

  01.01.2022

• The Efficacy of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin’s Lymphoma and Quality of Life: Results of a Multi-Center Observational Prospective Study in the Context of Real Clinical Practice

  T.I. Ionova, A.A. Amdiev, M.I. Andrievskikh, E.A. Baryakh, E.V. Vasilev, M.V. Volkov, E.M. Volodicheva, V.V. Ivanov, O.V. Kaverina, K.D. Kaplanov, T.Yu. Klitochenko, V.I. Kurakin, D.G. Lazareva, O.G. Larionova, K.V. Lepik, I.B. Lysenko, V.Ya. Melnichenko, R.I. Minullina, O.V. Mironov, E.N. Misyurina, N.B. Mikhailova, N.E. Mochkin, Tatyana Pavlovna Nikitina, T.S. Petrova, N.M. Porfireva, O.A. Rukavitsyn, A.A. Samoilova, R.N. Safin, P.I. Simashova, E.G. Smirnova, N.A. Trenina, N.V. Fadeeva, G.N. Khusainova, V.L. Chang, T.V. Shelekhova, D.G. Sherstnev

  42-53

  01.01.2022

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

  Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev

  308-314

  01.07.2021

• Retrospective Survival Analysis of Multiple Myeloma Patients after Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, Zh.Yu. Sidorova, N.Yu. Semenova, E.V. Karyagina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev

  73-79

  01.01.2021

• Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)

  Vladislav Olegovich Sarzhevskii, E.A. Demina, N.E. Mochkin, A.A. Spornik, A.A. Mamedova, E.G. Smirnova, A.E. Bannikova, A.A. Samoilova, V.S. Bogatyrev, V.Ya. Melnichenko

  53-62

  01.01.2021

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas

  V.O. Sarzhevskii, Anastasiya Aleksandrovna Samoilova, V.Ya. Melnichenko, Yu.N. Dubinina, N.E. Mochkin, D.S. Kolesnikova, D.A. Fedorenko, E.G. Smirnova, A.E. Bannikova, V.S. Bogatyrev

  185-192

  01.04.2020

• Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

  Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya

  25-32

  01.01.2020

• Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov

  247-262

  01.07.2019

• Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

  S.V. Gritsaev, Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, E.V. Karyagina, Zh.V. Chubukina, S.A. Tiranova, I.S. Martynkevich, S.S. Bessmeltsev, A.V. Chechetkin

  282-288

  01.07.2019

• Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

  Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov

  21-31

  01.01.2019

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia

  I.Z. Zavodnova, M.Yu. Kichigina, E.V. Paramonova, Yu.E. Ryabukhina, O.A. Kolomeitsev, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, N.V. Kokosadze, Gayane Sergeevna Tumyan

  59-67

  01.01.2019

• Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

  Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko

  360-367

  01.10.2018

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

  Nikita Evgen’evich Mochkin, V.O. Sarzhevskii, Yu.N. Dubinina, E.G. Smirnova, D.A. Fedorenko, A.E. Bannikova, D.S. Kolesnikova, V.S. Bogatyrev, N.M. Faddeev, V.Ya. Mel’nichenko

  234-240

  01.07.2018

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

  Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev

  187-191

  01.04.2018

• Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

  Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey

  167-174

  01.04.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia

  Elena Aleksandrovna Stadnik, N.S. Timofeeva, V.V. Strugov, A.Yu. Zaritskey

  42-49

  01.01.2018

• First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov

  443-452

  01.10.2017

• The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, A.A. Osipova, T.L. Gindina, A.I. Shakirova, T.A. Bykova, A.D. Kulagin, I.A. Samorodova, E.V. Karyakina, E.A. Ukrainchenko, L.S. Zubarovskaya, B.V. Afanas’ev

  351-357

  01.07.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region

  Varvara Ivanovna Bakhtina, I.V. Demko, A.N. Narkevich, D.S. Gushchin

  413-419

  01.10.2016

• Chronic Lymphocytic Leukemia: Prognostic Significance of Minimal Residual Disease and Potential of Modern Methods of Its Diagnosis and Therapy (Literature Review)

  A.Yu. Kuvshinov, Sergei Vladimirovich Voloshi, I.S. Martynkevich, E.V. Kleina, M.A. Mikhaleva, K.M. Abdulkadyrov

  191-198

  01.04.2016

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013

• Radiotherapy in combined treatment of patients with diffuse large B-cell lymphoma

  Yu.N. Vinogradova, N.V. Ilin, D.V. Larionov, M.M. Khodzhibekova, N.A. Kostenikov, L.I. Korytova

  415-420

  01.10.2013